| 摘要 |
FIELD: pharmaceutics. ^ SUBSTANCE: the present innovation deals with new pharmaceutical compositions based upon medicinal preparation (hydroxymatairesinol) to prevent cancer, hormonallydependent disease or cardio-vascular disease; new methods of prophylaxis including introduction of the above-mentioned compositions, methods to increase blood enterolacton level due to introducing hydroxymatairesinol, food supplement, food product and method to increase resistance of the above-mentioned product. New fields for applying hydroxymatairesinol are efficient due to its anti-tumor, antioxidant activity and body metabolism to enterolacton which, in its turn, is considered to be an inhibitor of aromatase. ^ EFFECT: increased number of preparation of the mentioned indication. ^ 16 cl, 5 dwg, 5 tbl |
